Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway | Synapse
August 1, 2015Open Access
Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
Puntos clave
Los puntos clave no están disponibles para este artículo en este momento.